Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yes, you probably are right, something big is brewing
A nice CFO with extended experience in many aspects.
Mr. Michael Pollack | Interim CFO
Michael Pollack, CPA is the Partner-in-Charge of KBL’s audit quality and control, and the Partner-in-Charge of KBL’s Public Company (SEC) Practices Group. He has over 20 years of experience in public accounting and consulting to both publicly traded and privately held companies. He also has a vast knowledge of capital financing, debt refinancing, strategic repositioning, development restructuring, and private placement offerings.
Michael’s specialties include reverse merger transactions and registration processes for the Securities and Exchange Commission. Prior to joining KBL Michael had been a director in regional firms specializing in the development and growth of their SEC practice. He has directed various SEC engagements as well as financial service engagements as an auditor, and has been utilized as an outsourced CFO for a number of public companies all performed in accordance with the standards established by the Public Company Accounting Oversight Board. He has prepared numerous market and financial feasibility studies that have directly led to the raising of several billion of dollars in financing.
Michael graduated from the University of Maryland with a Bachelors of Arts in Economics. Michael is a member of the American Institute of Certified Public Accountants, as well as licensed to practice in New Jersey, Pennsylvania, New York and Maryland.
good message and noted
We hope the best and wait in patience! Let the CEO and management team do the work, funds will come when the significant results are achieved. News is coming soon!
Be strong, be more confident! it does not take that long! once the five dog serial trials finished well, while FDA approves the human clinical trial, this will be trending very high beyond what we can expect.
great post, that is the true faith in this new option of fighting cancers.
We are looking forward to another productive year in 2019.
Our strategic objectives are:
1. Initiate the commercial sales of IsoPet.
2. Secure adequate funding to expand IsoPet therapy in key regional centers.
3. Begin the pre-clinical testing for human therapy.
4. File for additional patent(s) to enhance our intellectual property protection.
5. Continue to reduce production costs to make IsoPet more affordable for the average pet owner.
6. We realize that our loyal shareholders have gone through many emotional peaks and valleys with respect to our share price. We believe that with the elimination of our toxic debt and our progress in the development of IsoPet and our pending human trial testing that these trying times are at an end. We will be taking further steps to strength our companys position while maximizing shareholder value in the near future. The Board of Directors appreciates the patience of our shareholders as we develop a legacy of advanced treatments for cancerous tumors.
hope Vivos gets funds to do the same training clinicians or oncologists about licensing the usage of isopet!
thank you for consistently positive and believe in this company, yes, although some did lose money here temporarily however eventually, patience will be rewarded. Solid tech, solid progress, solid management and realistic strategy to get in animal clinics first then human, believe big partner or investor will join in this venture soon or later.
RDGL is much undervalued, yes totally 2B shares are huge, but it should value 10 times of its current value now, so at least we can see 0.1 dollars soon or later, but for sure it is not far.
That is the leader of vivos I liked, not money centered but mission centered, He will be appreciated eventually.
thank you TF, that is what I like to know. Great thing is gonna to happen
me too, if goes low, I will be selling other positions and go all in with great confidence
guys, this guy is sincere and real
Considering the CFO only work 5 hrs a week, it takes 2 months for finishing that commitment, therefore something may show up at the end of Jan or the beginning of Feb.
looks like engagement with the new interim CFO was a temporary thing, who was needed for solving a specific issue there.
I got it, lt is matter of time, let them do the work and patience gets rewards this year
this is a good sign, which indicates lots of accumulation!
American is the same
Do not miss reading this, Vivos is working with the best professionals
https://www.radiogel.com/about-1/management-consultants/
http://www.wci-ici.org/bbs/president.php
Dr. Nigel R. Stevenson is chief science office for vivos, he is also the president of The World Council on Isotopes (WCI), he is great people for Vivos to spread the great news about RDGL to the world. This is too nice!
good finding! Smart route of making Isopet first then Radiogel
bold prediction, but need to dream in case it comes true!
hi sister, you are a genius detective!
Hope all the coincidence becomes real, it is good for animal patients and for investors.
see the Qbiotics pipelines, they are serious
rdgl-a-look-back-on-the-last-10-years
https://otc.watch/forums/topic/rdgl-a-look-back-on-the-last-10-years/
we will see whether it is fact or rumor. until next Tuesday to prove it.
Great Job Den4, RDGL should hire you as director of public relations
that is a convincing point, they are dependent on each other, like golden team. Human trial will come soon after 5 dogs treatment, a matter of time, patience is the key
who has friends from Mideast countries, tell them the great things about isopet and radiogel, they have lots of money to invest in this!
Can not agree any more, patience is the key
It was great you have done this! The president of Chinese nuclear medicine will reward you
China is a huge market, I will ask friends there to spread the words about radiogel
Nice, how rich are you dreaming?
do not talk just buy
thank you for sharing Fairy, Hope the missy getting better and better
How did you know that? can you share factual info?
Probably Missy is waiting for getting injections of isopet, but very soon.
News should be getting closer
According to the twitter of radiogel,
When it comes to our product quality and state of the art patented delivery system we will not compromise. Thank you. #RadioGel™ #IsoPet® #cancertreatment #savinglives #curepetcancer #qualityassurance pic.twitter.com/ehs4dIjb8U
— RadioGel™ (@RadioGel) December 11, 2018
yes, RDGL is outsourcing the production of isopet to this great company, the quality control should be good
too old news
Originally published April 22, 2012 at 8:32 pm Updated April 22, 2012 at 11:04 pm
but good to knew where the original invention came from, PNNL is very famous national lab who is standing in the front of advancing techs and sciences.
Haha, too cheap now!
https://irdirect.net/prviewer/release/id/3558128
For human therapy we had outstanding response to our poster presentation at the Society of Nuclear Medicine and Medical Imaging (SNMMI) Conference in Philadelphia. We were invited to submit a paper on new innovative technology to their technical journal and also had strong interest from the president of the China Society of Nuclear Medicine.
I trust your sincerity of sharing this. 500 M buy or 2B buy, who is smarter to snap the deal, we will see
This is great!!!
Vivos Inc. Announced Expanded Applications of IsoPet® for Veterinary Cancer Therapy. This is expediting the commercialization of Isopet and revenue- building. All the cases of effective treatment on animals like dogs, horses , will speed up the human clinical trial approval. Hope we see it this year.